7/31/2020, 6:30 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Sanofi SA

EU reserves 300 million doses of Sanofi vaccine

The European Commission confirmed on Friday it has reserved 300 million doses of the trial vaccine against COVID-19 manufactured by French pharmaceutical company Sanofi S.A.

"Today we took an important step with Sanofi to secure access to a future coronavirus vaccine for Europeans, the Commission's President Ursula von der Leyen said. "We are in talks with other companies about promising vaccines, based on diverse technologies. A vaccine will be a global good."

Earlier in the day, it was announced the United States government signed an agreement with Sanofi and GlaxoSmithKline to provide up to $2.1 billion for the coronavirus vaccine testing and manufacturing. The United Kingdom previously agreed with the company on reserving 60 million doses.

Breaking the News / JR